nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—abdominal aortic aneurysm	0.458	0.603	CbGaD
Captopril—MMP9—abdominal aortic aneurysm	0.301	0.397	CbGaD
Captopril—REN—abdominal aorta—abdominal aortic aneurysm	0.0173	0.134	CbGeAlD
Captopril—REN—renal vein—abdominal aortic aneurysm	0.0166	0.128	CbGeAlD
Captopril—REN—posterior vena cava—abdominal aortic aneurysm	0.0121	0.0936	CbGeAlD
Captopril—REN—renal artery—abdominal aortic aneurysm	0.0111	0.0862	CbGeAlD
Captopril—F2—posterior vena cava—abdominal aortic aneurysm	0.00843	0.0653	CbGeAlD
Captopril—ACE—thoracic aorta—abdominal aortic aneurysm	0.00585	0.0453	CbGeAlD
Captopril—MMP2—tunica intima—abdominal aortic aneurysm	0.00583	0.0452	CbGeAlD
Captopril—MMP9—tunica intima—abdominal aortic aneurysm	0.00507	0.0393	CbGeAlD
Captopril—ACE—renal artery—abdominal aortic aneurysm	0.00474	0.0367	CbGeAlD
Captopril—MMP2—hindlimb—abdominal aortic aneurysm	0.00326	0.0252	CbGeAlD
Captopril—MMP9—hindlimb—abdominal aortic aneurysm	0.00283	0.0219	CbGeAlD
Captopril—F2—leg—abdominal aortic aneurysm	0.00277	0.0214	CbGeAlD
Captopril—ACE—tunica intima—abdominal aortic aneurysm	0.0027	0.0209	CbGeAlD
Captopril—F2—hindlimb—abdominal aortic aneurysm	0.00247	0.0191	CbGeAlD
Captopril—REN—artery—abdominal aortic aneurysm	0.00217	0.0168	CbGeAlD
Captopril—MMP2—artery—abdominal aortic aneurysm	0.002	0.0155	CbGeAlD
Captopril—MMP9—artery—abdominal aortic aneurysm	0.00174	0.0134	CbGeAlD
Captopril—REN—blood plasma—abdominal aortic aneurysm	0.00163	0.0126	CbGeAlD
Captopril—F2—artery—abdominal aortic aneurysm	0.00151	0.0117	CbGeAlD
Captopril—ACE—hindlimb—abdominal aortic aneurysm	0.00151	0.0117	CbGeAlD
Captopril—MMP2—blood plasma—abdominal aortic aneurysm	0.0015	0.0116	CbGeAlD
Captopril—MMP9—blood plasma—abdominal aortic aneurysm	0.0013	0.0101	CbGeAlD
Captopril—F2—blood plasma—abdominal aortic aneurysm	0.00114	0.0088	CbGeAlD
Captopril—LTA4H—connective tissue—abdominal aortic aneurysm	0.00112	0.0087	CbGeAlD
Captopril—LTA4H—kidney—abdominal aortic aneurysm	0.000957	0.00741	CbGeAlD
Captopril—ACE—artery—abdominal aortic aneurysm	0.000925	0.00717	CbGeAlD
Captopril—REN—connective tissue—abdominal aortic aneurysm	0.000867	0.00672	CbGeAlD
Captopril—MMP2—connective tissue—abdominal aortic aneurysm	0.000797	0.00617	CbGeAlD
Captopril—LTA4H—spinal cord—abdominal aortic aneurysm	0.000745	0.00577	CbGeAlD
Captopril—REN—kidney—abdominal aortic aneurysm	0.000738	0.00572	CbGeAlD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.000708	0.00634	CbGpPWpGaD
Captopril—MMP9—Collagen degradation—MMP3—abdominal aortic aneurysm	0.000699	0.00626	CbGpPWpGaD
Captopril—ACE—blood plasma—abdominal aortic aneurysm	0.000694	0.00538	CbGeAlD
Captopril—MMP9—connective tissue—abdominal aortic aneurysm	0.000693	0.00537	CbGeAlD
Captopril—MMP2—kidney—abdominal aortic aneurysm	0.000679	0.00526	CbGeAlD
Captopril—MMP9—IL1 and megakaryotyces in obesity—CCL2—abdominal aortic aneurysm	0.000657	0.00588	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—abdominal aortic aneurysm	0.000646	0.00578	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.000637	0.00571	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.000628	0.00562	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.000628	0.00562	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.000617	0.00553	CbGpPWpGaD
Captopril—F2—connective tissue—abdominal aortic aneurysm	0.000605	0.00469	CbGeAlD
Captopril—MMP9—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.000601	0.00538	CbGpPWpGaD
Captopril—MMP2—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.000599	0.00536	CbGpPWpGaD
Captopril—MMP9—kidney—abdominal aortic aneurysm	0.00059	0.00457	CbGeAlD
Captopril—MMP2—Osteopontin-mediated events—MMP9—abdominal aortic aneurysm	0.000583	0.00522	CbGpPWpGaD
Captopril—MMP2—Osteopontin-mediated events—NFKB1—abdominal aortic aneurysm	0.000577	0.00517	CbGpPWpGaD
Captopril—MMP2—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.000569	0.00509	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—MMP9—abdominal aortic aneurysm	0.000569	0.00509	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.000563	0.00504	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000558	0.00499	CbGpPWpGaD
Captopril—MMP9—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.000544	0.00487	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—NOS2—abdominal aortic aneurysm	0.000541	0.00484	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00054	0.00483	CbGpPWpGaD
Captopril—F2—Regulation of IGF Activity by IGFBP—MMP2—abdominal aortic aneurysm	0.000537	0.00481	CbGpPWpGaD
Captopril—MMP2—spinal cord—abdominal aortic aneurysm	0.000529	0.00409	CbGeAlD
Captopril—MMP9—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.000523	0.00468	CbGpPWpGaD
Captopril—F2—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.000519	0.00464	CbGpPWpGaD
Captopril—F2—kidney—abdominal aortic aneurysm	0.000515	0.00399	CbGeAlD
Captopril—F2—Cell surface interactions at the vascular wall—SELL—abdominal aortic aneurysm	0.000514	0.0046	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—MMP2—abdominal aortic aneurysm	0.000509	0.00456	CbGpPWpGaD
Captopril—F2—Blood Clotting Cascade—SERPINE1—abdominal aortic aneurysm	0.000508	0.00454	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—CCL2—abdominal aortic aneurysm	0.000507	0.00454	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—abdominal aortic aneurysm	0.000506	0.00453	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.000496	0.00444	CbGpPWpGaD
Captopril—MMP9—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.000496	0.00444	CbGpPWpGaD
Captopril—MMP2—Collagen degradation—MMP9—abdominal aortic aneurysm	0.000496	0.00444	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000494	0.00442	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.000486	0.00435	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—MMP9—abdominal aortic aneurysm	0.000467	0.00418	CbGpPWpGaD
Captopril—MMP9—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.000465	0.00416	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.000465	0.00416	CbGpPWpGaD
Captopril—MMP9—spinal cord—abdominal aortic aneurysm	0.00046	0.00356	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000444	0.00397	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.000442	0.00396	CbGpPWpGaD
Captopril—SLC15A1—kidney—abdominal aortic aneurysm	0.000439	0.0034	CbGeAlD
Captopril—MMP2—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.000435	0.0039	CbGpPWpGaD
Captopril—MMP9—Collagen degradation—MMP2—abdominal aortic aneurysm	0.000433	0.00387	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00042	0.00376	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.000412	0.00369	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000412	0.00369	CbGpPWpGaD
Captopril—MMP2—EPH-ephrin mediated repulsion of cells—MMP9—abdominal aortic aneurysm	0.000411	0.00368	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—MMP2—abdominal aortic aneurysm	0.000407	0.00364	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.000405	0.00362	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.000403	0.0036	CbGpPWpGaD
Captopril—F2—spinal cord—abdominal aortic aneurysm	0.000401	0.00311	CbGeAlD
Captopril—ACE—Peptide hormone metabolism—AGT—abdominal aortic aneurysm	0.000397	0.00356	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—abdominal aortic aneurysm	0.000397	0.00356	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.000394	0.00352	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—abdominal aortic aneurysm	0.000392	0.00351	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—LDLR—abdominal aortic aneurysm	0.000387	0.00346	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.000384	0.00343	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—NFKB1—abdominal aortic aneurysm	0.000379	0.00339	CbGpPWpGaD
Captopril—MMP9—Collagen formation—MMP3—abdominal aortic aneurysm	0.000371	0.00332	CbGpPWpGaD
Captopril—ACE—connective tissue—abdominal aortic aneurysm	0.00037	0.00286	CbGeAlD
Captopril—MMP9—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.000369	0.0033	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—MMP9—abdominal aortic aneurysm	0.000363	0.00325	CbGpPWpGaD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—abdominal aortic aneurysm	0.000359	0.00321	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.000359	0.00321	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.000354	0.00317	CbGpPWpGaD
Captopril—ALB—HDL-mediated lipid transport—APOE—abdominal aortic aneurysm	0.000349	0.00312	CbGpPWpGaD
Captopril—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00034	0.00263	CbGeAlD
Captopril—MMP9—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.000339	0.00303	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	0.000333	0.00298	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.00033	0.00295	CbGpPWpGaD
Captopril—F2—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.000328	0.00293	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—MMP9—abdominal aortic aneurysm	0.000327	0.00292	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.000324	0.0029	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.000323	0.00289	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.000319	0.00285	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000315	0.00282	CbGpPWpGaD
Captopril—ACE—kidney—abdominal aortic aneurysm	0.000315	0.00244	CbGeAlD
Captopril—MMP9—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000297	0.00266	CbGpPWpGaD
Captopril—F2—Syndecan-4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.000288	0.00258	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.000286	0.00256	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—MMP2—abdominal aortic aneurysm	0.000285	0.00255	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.000279	0.0025	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.000278	0.00249	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.000277	0.00248	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—abdominal aortic aneurysm	0.000273	0.00245	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.000268	0.0024	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.00026	0.00233	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000259	0.00232	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—LDLR—abdominal aortic aneurysm	0.000257	0.0023	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.000253	0.00226	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.000252	0.00225	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.000251	0.00225	CbGpPWpGaD
Captopril—ACE—spinal cord—abdominal aortic aneurysm	0.000245	0.0019	CbGeAlD
Captopril—ABCB1—blood plasma—abdominal aortic aneurysm	0.000244	0.00189	CbGeAlD
Captopril—F2—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.000243	0.00218	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000243	0.00218	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—MMP9—abdominal aortic aneurysm	0.00024	0.00215	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—abdominal aortic aneurysm	0.000238	0.00213	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000235	0.0021	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—SERPINE1—abdominal aortic aneurysm	0.000231	0.00206	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00023	0.00206	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	0.000228	0.00204	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AAAS—abdominal aortic aneurysm	0.000226	0.00203	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000226	0.00202	CbGpPWpGaD
Captopril—F2—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000226	0.00202	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.000219	0.00196	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	0.000219	0.00196	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—NFKB1—abdominal aortic aneurysm	0.000212	0.0019	CbGpPWpGaD
Captopril—F2—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000211	0.00189	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—MMP2—abdominal aortic aneurysm	0.00021	0.00188	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.000207	0.00185	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.000206	0.00184	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000204	0.00183	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.000204	0.00182	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—APOE—abdominal aortic aneurysm	0.0002	0.00179	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.000199	0.00179	CbGpPWpGaD
Captopril—LTA4H—Metabolism—LDLR—abdominal aortic aneurysm	0.000198	0.00177	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000196	0.00176	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000184	0.00165	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.000184	0.00164	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000179	0.00161	CbGpPWpGaD
Captopril—CYP2D6—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00017	0.00152	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.000169	0.00152	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.000168	0.0015	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000167	0.0015	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.000167	0.0015	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.000163	0.00146	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.00016	0.00143	CbGpPWpGaD
Captopril—F2—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.00016	0.00143	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000158	0.00141	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—abdominal aortic aneurysm	0.000156	0.0014	CbGpPWpGaD
Captopril—CYP2D6—kidney—abdominal aortic aneurysm	0.000154	0.00119	CbGeAlD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000151	0.00136	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000151	0.00136	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.00015	0.00134	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000148	0.00133	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000146	0.00131	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00014	0.00126	CbGpPWpGaD
Captopril—F2—Hemostasis—SELL—abdominal aortic aneurysm	0.000139	0.00125	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.000138	0.00124	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000137	0.00123	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000135	0.00121	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—APOE—abdominal aortic aneurysm	0.000133	0.00119	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000132	0.00118	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.000131	0.00117	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.00013	0.00116	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000127	0.00114	CbGpPWpGaD
Captopril—F2—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000125	0.00112	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000119	0.00107	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.000118	0.00105	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.000117	0.00105	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000112	0.001	CbGpPWpGaD
Captopril—ABCB1—kidney—abdominal aortic aneurysm	0.000111	0.000858	CbGeAlD
Captopril—ALB—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.00011	0.000985	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000107	0.000954	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000105	0.000941	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AGT—abdominal aortic aneurysm	0.000105	0.000935	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000104	0.000928	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000103	0.000925	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000103	0.00092	CbGpPWpGaD
Captopril—LTA4H—Metabolism—APOE—abdominal aortic aneurysm	0.000102	0.000917	CbGpPWpGaD
Captopril—CYP2D6—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.000101	0.000904	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	9.69e-05	0.000867	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	9.66e-05	0.000865	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	9.18e-05	0.000821	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	9e-05	0.000806	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—CCL2—abdominal aortic aneurysm	8.96e-05	0.000802	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MMP9—abdominal aortic aneurysm	8.93e-05	0.000799	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	8.7e-05	0.000779	CbGpPWpGaD
Captopril—ABCB1—spinal cord—abdominal aortic aneurysm	8.62e-05	0.000668	CbGeAlD
Captopril—F2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	8.54e-05	0.000764	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	8.36e-05	0.000748	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—AGT—abdominal aortic aneurysm	8.35e-05	0.000747	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	8.01e-05	0.000717	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	7.93e-05	0.00071	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	7.89e-05	0.000706	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	7.87e-05	0.000705	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MMP2—abdominal aortic aneurysm	7.79e-05	0.000697	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	7.79e-05	0.000697	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	7.7e-05	0.000689	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—AGT—abdominal aortic aneurysm	7.5e-05	0.000672	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	7.33e-05	0.000656	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	7.2e-05	0.000645	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—SERPINE1—abdominal aortic aneurysm	7.17e-05	0.000642	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	7.12e-05	0.000637	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—abdominal aortic aneurysm	7.02e-05	0.000628	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CCL2—abdominal aortic aneurysm	6.87e-05	0.000615	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	6.83e-05	0.000611	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	6.64e-05	0.000595	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	6.5e-05	0.000582	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—abdominal aortic aneurysm	6.37e-05	0.00057	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—NFKB1—abdominal aortic aneurysm	6.34e-05	0.000567	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NFKB1—abdominal aortic aneurysm	6.3e-05	0.000564	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CCL2—abdominal aortic aneurysm	6.18e-05	0.000553	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AGT—abdominal aortic aneurysm	6.01e-05	0.000538	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LRP1—abdominal aortic aneurysm	5.89e-05	0.000527	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP2—abdominal aortic aneurysm	5.88e-05	0.000526	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	5.8e-05	0.000519	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MMP2—abdominal aortic aneurysm	5.56e-05	0.000498	CbGpPWpGaD
Captopril—ALB—Hemostasis—SELL—abdominal aortic aneurysm	5.53e-05	0.000495	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—P2RY12—abdominal aortic aneurysm	5.51e-05	0.000493	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	5.03e-05	0.000451	CbGpPWpGaD
Captopril—ALB—Hemostasis—P2RY12—abdominal aortic aneurysm	4.98e-05	0.000446	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	4.95e-05	0.000443	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—abdominal aortic aneurysm	4.91e-05	0.000439	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	4.83e-05	0.000432	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LRP1—abdominal aortic aneurysm	4.55e-05	0.000407	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LDLR—abdominal aortic aneurysm	4.46e-05	0.0004	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	4.38e-05	0.000392	CbGpPWpGaD
Captopril—F2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	4.25e-05	0.000381	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—AGT—abdominal aortic aneurysm	4.23e-05	0.000378	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NCF1—abdominal aortic aneurysm	4.18e-05	0.000374	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NFKB1—abdominal aortic aneurysm	4.13e-05	0.00037	CbGpPWpGaD
Captopril—F2—Hemostasis—SERPINE1—abdominal aortic aneurysm	4.13e-05	0.00037	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	4e-05	0.000358	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	3.91e-05	0.00035	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	3.67e-05	0.000329	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	3.5e-05	0.000314	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—abdominal aortic aneurysm	3.48e-05	0.000312	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LDLR—abdominal aortic aneurysm	3.45e-05	0.000308	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	3.4e-05	0.000304	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR1—abdominal aortic aneurysm	3.35e-05	0.0003	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—abdominal aortic aneurysm	3.31e-05	0.000296	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NCF1—abdominal aortic aneurysm	3.22e-05	0.000289	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	3.18e-05	0.000285	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGT—abdominal aortic aneurysm	3.08e-05	0.000276	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MMP3—abdominal aortic aneurysm	2.99e-05	0.000267	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	2.73e-05	0.000245	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	2.59e-05	0.000232	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	2.54e-05	0.000227	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	2.37e-05	0.000212	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGT—abdominal aortic aneurysm	2.36e-05	0.000211	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—abdominal aortic aneurysm	2.31e-05	0.000207	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP3—abdominal aortic aneurysm	2.31e-05	0.000207	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—abdominal aortic aneurysm	1.95e-05	0.000174	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—abdominal aortic aneurysm	1.94e-05	0.000174	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	1.94e-05	0.000174	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	1.9e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Metabolism—AAAS—abdominal aortic aneurysm	1.87e-05	0.000168	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—abdominal aortic aneurysm	1.82e-05	0.000163	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	1.81e-05	0.000162	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—abdominal aortic aneurysm	1.78e-05	0.00016	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	1.64e-05	0.000147	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—abdominal aortic aneurysm	1.64e-05	0.000147	CbGpPWpGaD
Captopril—ALB—Metabolism—LDLR—abdominal aortic aneurysm	1.64e-05	0.000146	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	1.55e-05	0.000138	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—abdominal aortic aneurysm	1.5e-05	0.000134	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	1.43e-05	0.000128	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	1.4e-05	0.000125	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.37e-05	0.000123	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	1.35e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.3e-05	0.000117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.07e-05	9.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.06e-05	9.5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—abdominal aortic aneurysm	8.64e-06	7.74e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—abdominal aortic aneurysm	8.47e-06	7.58e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	7.57e-06	6.78e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	7.42e-06	6.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	7.14e-06	6.39e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	6.99e-06	6.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—abdominal aortic aneurysm	5.8e-06	5.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	5.08e-06	4.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	4.79e-06	4.29e-05	CbGpPWpGaD
